Eli Lilly and the Obesity Market: Sizing a Forecast That Keeps Getting Bigger
Lilly’s quarterly revenue now annualizes to $92B, 3.2x fiscal 2022, while its P/E sits at 38.7 against a five-year average of 67.5. We work backwards from the $1,153 price to the revenue needed to justify…